The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Cancer cachexia (CC) is a debilitating multifactorial syndrome, involving progressive
deterioration and functional impairment of skeletal muscles. It affects about 80% of patients …

Background Elderly pancreatic cancer (PC) patients are often considered vulnerable to
treatment and standard treatment strategy for this subpopulation is uncertain. Cachexia and …

Background Despite rehabilitation being increasingly advocated for people living with
incurable cancer, there is limited evidence supporting efficacy or component parts. The …

Simple Summary Advanced cancer represents the most common reason for needing
palliative care among older adults worldwide. Unfortunately, older adults face several …

Objective Anamorelin, a novel selective ghrelin receptor agonist, was approved in Japan for
the treatment of cachexia in pancreatic cancer (PC), albeit with limited evidence. This study …

PURPOSE The burden of cancer cachexia on patients' health-related quality of life,
specifically their physical functioning, is well documented, but clinical trials thus far have …

Introduction: Pancreatic cancer requires a multidisciplinary approach in a high-volume
center for all the steps of the diagnostic-therapeutic course. However, the most experienced …

Cancer cachexia is a complex syndrome for which multidisciplinary management through
collaboration has the potential to improve patient outcomes and efficiency of care, through …

Objectives Gastric cancer is among the most common and lethal cancers worldwide.
Recently, studies have reported that myosteatosis is a prognosticator for adverse survival …